Patents Assigned to Merck Frost Canada & Co.
  • Cathespin cysteine protease inhibitors
    Patent number: 7312353
    Abstract: This invention relates to a novel class of compounds, represented by the formula below, wherein the meanings of G, E, E, n, R1, R2, R3 et R4 are indicated therein, which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
    Type: Grant
    Filed: August 19, 2004
    Date of Patent: December 25, 2007
    Assignee: Merck Frost Canada & Co.
    Inventors: Jacques Yves Gauthier, Vouy Linh Truong